HHealthcare Read More Eli Lilly (LLY) earnings Q4 2025February 4, 2026 Eli Lilly on Wednesday posted fourth-quarter earnings and revenue and 2026 guidance that blew past estimates, as demand…
HHealthcare Read More Pfizer’s monthly obesity injection drove shows promise in trialFebruary 3, 2026 Smith Collection | Archive Photos | Getty Images Pfizer on Thursday said its experimental obesity drug, which it…
HHealthcare Read More Eli Lilly CEO David Ricks talks Medicare coverage of obesity pillsJanuary 30, 2026 Eli Lilly CEO Dave Ricks on Friday said upcoming Medicare coverage of obesity drugs could be a major…
HHealthcare Read More Eli Lilly plans $3.5 billion Pennsylvania plant for obesity drugsJanuary 30, 2026 Eli Lilly Chair and CEO Dave Ricks speaks during a press conference in Houston, Sept. 23, 2025. Antranik…
HHealthcare Read More Next steps for Eli Lilly, Novo Nordisk, PfizerJanuary 23, 2026 A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, Jan. 15, 2026. George…
HHealthcare Read More Novo Nordisk shares rise after Wegovy obesity pill launchJanuary 16, 2026 A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, US, on Thursday, Jan.…
HHealthcare Read More First GLP-1 pill for obesity from Novo Nordisk launches in the U.S.January 5, 2026 The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the…
MMedication Read More Novo Nordisk beyond weight loss has investors wary, scientists hopefulJanuary 1, 2026 Ozempic is medicine for adults with type 2 diabetes that along with diet and exercise may improve blood…
HHealthcare Read More Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on saleDecember 23, 2025 Jim Cramer says don’t sweat Novo Nordisk’s head start over Club holding Eli Lilly in the obesity pill…
HHealthcare Read More Obesity pills from Novo Nordisk, Eli Lilly are comingDecember 16, 2025 Daniel Grill | Tetra Images | Getty Images A version of this article first appeared in CNBC’s Healthy…
MMedication Read More Eli Lilly’s weight loss drug retatrutide clears first late-stage studyDecember 12, 2025 The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025. Mike…
HHealthcare Read More WHO backs use of GLP-1 therapies for obesity, warns access will remain limitedDecember 2, 2025 A view shows The World Health Organization (WHO) headquarters in Geneva, Switzerland, Jan. 28, 2025. Denis Balibouse |…